Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05457010
Title Phase I Study of Cell Therapies for the Treatment of Patients With Relapsed or Refractory AML or High-risk MDS
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Arcellx, Inc
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.